Spartan Bioscience Inc.
Integrated DNA testing systems that perform sample collection, extraction, and analysis in a single device
- Sector
- Medtech
- Headquarters
- Nepean, A6
- Founded
- 2005
- Latest Form D
- $24K, Apr 2013
- Total capital
- $284K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $284K
- 3 Form D · last Apr 2013
- 163 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 5 pending · first 2017
- Rank in peer group#255 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$24K
- Private capital raisedForm D · SEC · 2nd filing$110K
- Private capital raisedForm D · SEC · 1st filing$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#255 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alan ShayanpourExecutive OfficerNamed in SEC Form D filings
- Jamie SpiegelmanDirectorNamed in SEC Form D filings
- Jamie SpieglemanDirectorNamed in SEC Form D filings
- John LemDirectorNamed in SEC Form D filings
- Ken PaigeDirectorNamed in SEC Form D filings
- Lawrence D'AndreaExecutive Officer, DirectorNamed in SEC Form D filings
Show all 12 people
- Mark HoughtingExecutive OfficerNamed in SEC Form D filings
- Mark KersheyExecutive OfficerNamed in SEC Form D filings
- Michael AbramsExecutive OfficerNamed in SEC Form D filings
- Michael StorkDirectorNamed in SEC Form D filings
- Paul LemDirectorNamed in SEC Form D filings
- Paul MarkellExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 12- GrantedFluid Handling ApparatusUSPTOUS 12,060,548
- PendingDirect Nucleic Acid Analysis Of Environmental And Biological SamplesUSPTOApplication 16608014
- PendingLinearly-amplified Internal Control For Nucleic Acid Amplification ReactionUSPTOApplication 16981134
Show all 12 patent records
- Fluid Handling ApparatusAug 13, 2024 · US 12,060,548Granted
- Direct Nucleic Acid Analysis Of Environmental And Biological SamplesApr 8, 2021 · Application 16608014Pending
- Linearly-amplified Internal Control For Nucleic Acid Amplification ReactionFeb 25, 2021 · Application 16981134Pending
- Concentration Detector For Laboratory UseDec 31, 2019 · US D,871,607Granted
- Systems And Methods For Nucleic Acid AmplificationAug 27, 2019 · US 10,391,498Granted
- Light-absorbing Optical Fiber-based Systems And MethodsJun 13, 2019 · Application 16324491Pending
- SWABNov 20, 2018 · US D,834,215Granted
- Diagnostic DeviceMay 8, 2018 · US D,817,509Granted
- CartridgeApr 3, 2018 · US D,814,652Granted
- Direct Nucleic Acid AnalysisMar 14, 2017 · US 9,593,369Granted
- Optical Fiber With Grating And Particulate CoatingMay 21, 2015 · Application 14409429Pending
- Systems And Methods For Nucleic Acid AmplificationApplication 62266080Pending
Related companies, and why
- bioTheranostics, Inc.Similar federal contract value in Medtech · null in contracts
- Roadio, Inc.Similar federal contract value in Medtech · null in contracts
- MILESTONE SCIENTIFIC INC.Similar federal contract value in Medtech · null in contracts
- NOVIAN HEALTH INC.Similar federal contract value in Medtech · null in contracts
- VistaPath Biosystems, Inc.Similar federal contract value in Medtech · null in contracts
- Koya Medical, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .